First-in-human tandem Terbium-161 and Actinium-225 PSMA radioligand therapy in metastatic castration-resistant prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging 2026

View at publisher
Authors: Omer Aras, Kezban Berberoğlu
DOI: 10.1007/s00259-026-07785-7
Cited by: 1
References: 3

Fields of Study & Subjects

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Peptidase Inhibition and Analysis

Publication details

Journal / source
European Journal of Nuclear Medicine and Molecular Imaging
Publisher
Springer Science and Business Media LLC
Volume
53
Issue
8
Pages
4792–4793
Publication date
2 February 2026
Language
EN